Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?
Stoke Therapeutics Ownership Summary
Stoke Therapeutics is owned by 116.35% institutional investors, 3.82% insiders. Blackrock is the largest institutional shareholder, holding 11.70% of STOK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.
STOK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Stoke Therapeutics | 116.35% | 3.82% | -20.17% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 5.41M | 11.70% | $73.08M |
| Rtw investments, lp | 5.62M | 9.50% | $183.10M |
| Blackrock funding, inc. /de | 5.39M | 9.09% | $175.36M |
| Fmr | 5.38M | 9.09% | $175.29M |
| Lynx1 capital management lp | 4.76M | 8.04% | $155.11M |
| Cowen and company | 3.37M | 7.28% | $45.47M |
| Redmile group | 4.16M | 7.03% | $135.58M |
| Morgan stanley | 3.42M | 5.78% | $111.46M |
| Baker bros. advisors lp | 3.34M | 5.63% | $108.64M |
| Vanguard group | 3.15M | 5.37% | $99.96M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Skorpios trust | 2.26M | 99.68% | $53.02M |
| Lynx1 capital management lp | 4.76M | 24.51% | $155.11M |
| Redmile group | 4.16M | 8.98% | $135.58M |
| Birchview capital, lp | 210.00K | 3.89% | $6.84M |
| Opaleye management | 700.00K | 3.00% | $22.79M |
| Bvf inc/il | 2.55M | 2.64% | $82.95M |
| Bioimpact capital | 767.04K | 1.93% | $24.97M |
| Rtw investments, lp | 5.62M | 1.82% | $183.10M |
| Siren | 2.00M | 1.80% | $64.97M |
| Checkpoint capital | 212.05K | 1.67% | $4.98M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 3.10M | 0.02% | 2.36M |
| Price t rowe associates inc /md/ | 1.93M | 0.01% | 1.56M |
| Blackrock | 5.41M | 0.00% | 1.55M |
| Troluce capital advisors | 652.80K | 1.30% | 652.80K |
| Millennium management | 472.14K | 0.01% | 472.14K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 18.90K | 0.00% | -1.43M |
| Healthcare of ontario pension plan trust fund | - | - | -1.39M |
| Point72 asset management | - | - | -1.22M |
| Logos global management lp | - | - | -1.05M |
| Skorpios trust | 2.26M | 99.68% | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Troluce capital advisors | 652.80K | 1.30% | 652.80K | $21.26M |
| Vanguard fiduciary trust | 356.95K | 0.00% | 356.95K | $11.62M |
| Artisan partners limited partnership | 315.49K | 0.02% | 315.49K | $10.27M |
| Norges bank | 314.80K | 0.00% | 314.80K | $3.47M |
| T. rowe price investment management | 250.91K | 0.01% | 250.91K | $8.17M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Mid-american wealth advisory group | -17.00 |
| Srs capital advisors | -21.00 |
| Lindbrook capital | -30.00 |
| Capital performance advisors llp | -32.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 200 | 3.63% | 68,902,374 | 2.86% | 116 | 0.89% | 116 | 13.73% | 54 | -8.47% |
| Dec 31, 2025 | 82 | -47.44% | 14,262,199 | -78.93% | 24 | 0.18% | 43 | -52.22% | 21 | -46.15% |
| Sep 30, 2025 | 64 | -49.61% | 15,482,785 | -74.37% | 26 | 0.25% | 38 | -47.95% | 16 | -44.83% |
| Jun 30, 2025 | 133 | 4.72% | 65,529,807 | 16.03% | 112 | 1.18% | 73 | 2.82% | 33 | 22.22% |
| Mar 31, 2025 | 128 | -2.29% | 63,381,918 | 9.17% | 109 | 1.03% | 70 | 4.48% | 28 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.61M | 2.97% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.73M | 2.78% | 5.96K |
| Vanguard Health Care Inv | 1.65M | 2.65% | 1.65M |
| State Street® SPDR® S&P® Biotech ETF | 1.24M | 1.99% | -12.40K |
| Fidelity Select Biotechnology | 1.21M | 1.94% | 413.80K |
| iShares Russell 2000 ETF | 1.16M | 1.86% | 9.73K |
| Polar Capital Biotech S Inc | 1.07M | 1.72% | - |
| BGF World Healthscience A2 USD | 851.11K | 1.56% | - |
| SPDR® S&P Biotech ETF | 626.96K | 1.14% | 1.40K |
| Fidelity Select Health Care | 680.00K | 1.09% | -70.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 01, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | $54.89K |
| May 01, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | $73.55K |
| Apr 01, 2026 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | $60.03K |
| Mar 20, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | $292.36K |
| Mar 20, 2026 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | $20.68K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 27 |
| 2025 Q4 | - | 42 |
| 2025 Q3 | - | 13 |
| 2025 Q2 | - | 5 |
STOK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools